duloxetine 20 MG Delayed Release Oral Capsule
1 INDICATIONS AND USAGE Duloxetine delayed-release capsules USP is a serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for: Major Depressive Disorder (MDD) ( 1 ) Generalized Anxiety Disorder (GAD) ( 1 ) Diabetic Peripheral Neuropathic Pain (DPNP) ( 1 ) Chronic Musculoskeletal Pain ( 1 ) Duloxetine is indicated for the treatment of: Major Depressive Disorder [see Clinical Studies ( 14.1 )] Generalized Anxiety Disorder [see Clinical Studies ( 14.2 )] Diabetic Peripheral Neuropathy [see Clinical Studies ( 14.3 )] Chronic Musculoskeletal Pain [see Clinical Studies ( 14.5 )]
Cipla USA Inc.
CAPSULE GREEN 297 Cipla
Related Pills
duloxetine capsule delayed release
cipla usa inc.
duloxetine capsule delayed release
cipla usa inc.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING 16.1 How Supplied Duloxetine delayed-release capsules USP are available in the following strengths, colors, imprints, and presentations: a equivalent to duloxetine base Features Strengths 20 mg a 30 mg a 60 mg a Body color Clear transparent Clear transparent Clear transparent Cap color Opaque green Opaque white Opaque blue Cap imprint 297 298 299 Body imprint Cipla Cipla Cipla Presentations and NDC Codes Bottles of 30 69097-297-02 69097-298-02 69097-299-02 Bottles of 60 69097-297-03 69097-298-03 69097-299-03 Bottles of 90 69097-297-05 69097-298-05 69097-299-05 Bottles of 1000 69097-297-15 69097-298-15 69097-299-15 16.2 Storage and Handling Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F). [seeUSP Controlled Room Temperature].
More pills like CAPSULE 297 Cipla